Phase 2 N=54 Study in Subjects Undergoing Complete Abdominoplasty
Postsurgical Pain
Primary: Pain Intensity Scores at 96 Hours at Rest Using Numerical Rating Scale (NRS) — 2.8; 2.0; 3.0; 2.8 score on a scale — p=0.2912
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=10 Evaluation of the Use of the Renuvion APR System in the Labia
Labia Enlarged · Labium; Hypertrophy
Primary: Evaluation of Change Between Baseline and Follow-up Images as Determined by a Masked, Qualitative Assessment of Photographs at 90-days and 180-days Post-treatment…
Phase 2 N=276 Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery
Postoperative Pain
Primary: Summed Pain Intensity Scores Collected Over 24 Hours — 92.60; 96.16 Units on a scale
Phase 2 N=40 Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty
Seroma · Hematoma
Primary: Total Drainage Volume Collected Until Drain Removal — 407.45; 595.90 mL
N/A N=15 DualSculpting the Abdomen Using CoolSculpting
Body Fat Disorder
Primary: Proportion of Correctly Identified Photos by Blinded Reviewers — 28 photos
N/A N=20 PEAK PlasmaBlade™ vs. Traditional Electrosurgery in Abdominoplasty
Elastosis
Primary: Acute Thermal Injury Depth — 195; 763 micrometers — p=<0.001
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001
N/A N=89 A Study to Evaluate Two Different Surgical Methods for Treatment for Abdominal Wall Diastasis
Abdominal Hernias and Other Abdominal Wall Conditions · Post-operative Pain · Recurrence
Primary: Recurrence of Diastasis One Year Post-operatively That Indicated by CT Scan or Clinical Investigation. — 2; 3; 26 Participants
Phase 3 N=219 Evaluation of N1539 Following Abdominoplasty Surgery
Pain, Post-operative
Primary: Summed Pain Intensity Difference Over the First 24 Hours (SPID24) — -4262.1; -3535.7 units on a scale — p=0.0145
N/A N=12 Clinical Evaluation of the GLYDe Dressing for Post-surgical Incision Care
Post Surgical Incisions From Abdominoplasty Procedures
Primary: Scar Evaluation at End of Treatment Period Comparing Treated to Standard of Care (Control) — 18.64; 50.52 score on a scale
N/A N=20 CoolSculpting in the Abdomen Using Applicator With and Without CCI
Body Fat Disorder
Primary: Percentage of Accurately Identified Pre-treatment Photos — 33; 23; 50; 23 photos
N/A N=75 Pre Operative Transversus Abdominis Plane Block Laparoscopic Gynecological Surgery
Pain · Surgery
Primary: The Quality of Recovery Questionnaire (QoR40) on the Day (24 Hours) After Surgery — 172; 157; 173 units on a scale — p=0.006
N/A N=278 Post-operative Patient Positioning Device for Improvement of Post-Operative Pain
Pain, Postoperative
Primary: Total Morphine Milliequivalent (MME) Use Postoperatively After Cesarean Delivery — 52; 68 Morphine milligram equivalents
Phase 2 N=10 Histopathology Following CCH Injection
Characteristics of Subcutaneous Tissue
Primary: Number of Participants With a Histologic Change in a Tissue Specimen That Was Injected With CCH — 2; 1; 1; 2 Participants
N/A N=60 Impact Of Post-Bariatric Body Contouring Procedures on Patient Body Weight and Metabolism
Bariatric Surgery Candidate
Primary: Weight Changes by Kilograms — 94.3; 96.17; 96.27; 89.4 Kilo gram
N/A N=16 OxyGenesys Dissolved Oxygen Dressing; Abdominoplasty at Northwestern University
Wounds
Primary: Healing in Days. — 13.1; 12.5 days
N/A N=70 SlimShape Device for Abdominal Fat and Circumference Reduction
Fat Disorder
Primary: Change in Fat Thickness at Final Follow-up Compared to Baseline — -1.76 millimeters
N/A N=62 UltraShape Power for Abdominal Fat and Circumference Reduction
Excess Abdominal Fat
Primary: Change in Abdominal Fat Thickness Compared to Baseline as Measured by Ultrasound — -10.5 percentage change
N/A N=425 A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects
Abdominal Wall Defects
Primary: Confirmed Hernia Recurrence — 20 participants
N/A N=75 Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.
Circumference Reduction of Abdomen
Primary: Evaluation of Change in Abdomen Circumference Using Tape Measurements in cm at the 3 Months Follow-up Visit Comparing to Baseline. — 89.5 CM
N/A N=12 Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Body Fat
Primary: Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response — 10; 0 Participants
N/A N=81 Effects of Different Surgical Methods to Treat Obesity
Obesity · Type 2 Diabetes · Insulin Sensitivity
Primary: Insulin Sensitivity at 2 Years — 6.7; 6.6 glucose/kg body weight/min
Phase 4 N=120 Parastomal Reinforcement With Strattice
Parastomal Hernia
Primary: Occurrence of Parastomal Hernia in Subjects Undergoing Permanent Abdominal Wall Ostomy Creation With and Without Strattice Fascial Inlay. — 6; 7 participants
N/A N=35 Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
Hernia Repair With Compartment Syndrome
Primary: Hernia Recurrence — 11; 12 percentage of patients
N/A N=25 Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature
Body Fat Disorder
Primary: Safety of the Zeltiq System for Non-invasive Fat Reduction in Subjects With Greater Flank Curvature. — 0; 0 UADEs
Phase 2 N=200 A Study of TRV130 for the Treatment of Pain After Abdominoplasty
Pain
Primary: Time Weighted Average (TWA) Change From Baseline in Pain Score Over 24 Hours Between TRV130 and Placebo — -3.8; -1.7; -3.5; -1.2 score on a scale
Phase 3 N=120 Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA
Breast - Female
Primary: Post-operative Narcotic Usage — 139.3; 169.2 milligrams (mg)
Phase 3 N=793 Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
Central Abdominal Bulging
Primary: Percentage of Subjects Who Achieved a Composite P-GAPS1/CPnS2 Response — 37; 48 Participants — p=0.397
N/A N=50 CoolSculpting and EMS for the Abdomen
Body Fat Disorder
Primary: Number of Unanticipated Adverse Device Effects (UADE) — 0; 0; 0; 0 events
N/A N=36 Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction
Surgical Incision
Primary: Patient and Observer Scar Assessment Scale (POSAS)- Patient Scores 12M — 1.09; 1.22; 1.3; 1.87 score on a scale